Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:06:12.806Z.
Calculation as of: 2026-10-06T17:06:12.806Z.
Quote observation: 2026-10-06T17:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f13a1340446ed9d2fab2f71bf594eb69a7c02e94fe434461414907d992f5ed7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Cullinan Therapeutics, Inc.
Market Cap
$1.04B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Operating Cash Flow Yield
8.20%
TTM Avg
7.29%
3Y Avg
7.32%
5Y Avg
6.78%
Market Cap
$1.05B
Operating Cash Flow Yield
24.81%
TTM Avg
24.50%
3Y Avg
20.47%
5Y Avg
14.92%
Market Cap
$1.03B
Operating Cash Flow Yield
N/A
TTM Avg
1.54%
3Y Avg
13.01%
5Y Avg
70.14%
Market Cap
$1.03B
Operating Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$1.03B
Operating Cash Flow Yield
4.13%
TTM Avg
6.70%
3Y Avg
7.23%
5Y Avg
7.23%
Market Cap
$1.02B
Operating Cash Flow Yield
6.33%
TTM Avg
6.00%
3Y Avg
6.00%
5Y Avg
6.00%
Market Cap
$1.08B
Operating Cash Flow Yield
2.51%
TTM Avg
2.27%
3Y Avg
2.68%
5Y Avg
2.53%
Market Cap
$1.00B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.04B | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 8.20% | 7.29% | 7.32% | 6.78% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 24.81% | 24.50% | 20.47% | 14.92% |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 1.54% | 13.01% | 70.14% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | N/A | 0.20% | 0.20% | 0.20% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | 4.13% | 6.70% | 7.23% | 7.23% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 6.33% | 6.00% | 6.00% | 6.00% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 2.51% | 2.27% | 2.68% | 2.53% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
